Creative Medical Technology Holdings, Inc. (CELZ) Gross margin 2017–2025
Creative Medical Technology Holdings, Inc. (CELZ) gross margin by fiscal year — reported gross profit divided by reported revenue.
63.4%FY2025 · since FY2017: -66.7% → 63.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 63.4% | +3.4 pp |
| FY2024 | 60.0% | +0.0 pp |
| FY2023 | 60.0% | -7.8 pp |
| FY2022 | 67.8% | +22.5 pp |
| FY2021 | 45.4% | -23.9 pp |
| FY2020 | 69.2% | -3.3 pp |
| FY2019 | 72.5% | +29.1 pp |
| FY2018 | 43.4% | +110.1 pp |
| FY2017 | -66.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CELZ financial trends
CELZ RevenueCELZ Net incomeCELZ Net marginCELZ Gross profitCELZ Operating incomeCELZ Operating marginCELZ Operating cash flowCELZ Free cash flowCELZ Capital expendituresCELZ Return on equityCELZ Stock buybacksCELZ Dividends paidCELZ Total assetsCELZ Total liabilitiesCELZ Shareholders’ equityCELZ overview →